tailieunhanh - Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study

The tyrosine kinase inhibitor pazopanib is used for treatment of sarcoma. Recent studies have suggested that the use of pazopanib may lead to the development of pneumothorax, an unexpected adverse effect in patients with sarcoma metastatic to the chest. | Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib a case control study

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN